ESSENCE

What ESSENCE does

ESSENCE (legal name: 泽达易盛（天津）科技股份有限公司) is a Chinese pharmaceutical industry digitalization vendor founded in 2013 and listed on the Shanghai STAR Market (Science and Technology Innovation Board) in June 2020 under stock code 688555. The company operates two business segments — Intelligent Manufacturing and Intelligent Supervision — and sells customized software, system integration, and technical services to pharmaceutical enterprises, government market supervision units, and retail pharmacies. According to company disclosures, it has delivered 180+ solutions to 100+ pharmaceutical enterprises, serves 100+ market supervision units, and reaches 10,000+ pharmacies across 22 provincial-level regions of China. Headcount is reported at 251–500 employees across offices in Tianjin (headquarters), Hangzhou (Zhejiang regional), and Suzhou (R&D / subsidiary).

ESSENCE's core product portfolio includes the TcmMES Manufacturing Execution System for pharmaceutical production, a Pharmaceutical Process Knowledge Management System, a Drug and Medical Device Circulation Control System, an AI-based Pharmacist On-Duty Management System featuring facial recognition, and three regulatory platforms — Drug Safety Supervision, Food Safety Supervision, and Medical Device Safety Supervision. The underlying technology stack combines cloud computing, big data, and applied AI for quality control, traceability, and regulatory compliance across the drug lifecycle (R&D → production → warehousing → distribution → sales). Revenue is generated through three streams: customized software solutions (recurring), system integration services (project-based), and ongoing technical services (recurring). Distribution is direct enterprise sales plus government procurement channels, with credibility anchored by the company's co-authorship of the global first ISO international standard in traditional Chinese medicine production processes (with Zhejiang University) and its designation as the sole pharmaceutical intelligent manufacturing system solutions provider by China's Ministry of Industry and Information Technology.

Name

ESSENCE

Legal name

Essence

Website

https://sino-essence.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

251–500 employees

Short description

ESSENCE (泽达易盛) provides customized software, system integration, and technical services for pharmaceutical digitalization across China, serving 100+ drug manufacturers, 100+ government regulators, and 10,000+ pharmacies with AI-enabled manufacturing and supervision platforms.

Ownership category

akta.pro rank

Product category

Pharmaceutical Digitalization Software / Regulated Industry Software

NAICS

Software Publishers (5132)

akta.pro primary industry

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

akta.pro secondary industries

Regulatory Submissions & Clinical Content Management (eCTD/Publishing) (HLACAOAN), Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)

Keywords

• Pharmaceutical digitalization
• Drug safety supervision
• Intelligent pharmaceutical manufacturing
• Regulatory compliance software
• Pharmaceutical MES systems

Headquarters

HQ city

Tanggu

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Customized Software Solutions: Provides tailored software solutions for pharmaceutical enterprises including quality control systems, production management, and regulatory compliance software
2. System Integration Services: Provides integrated technology solutions combining software and hardware for end-to-end pharmaceutical supply chain management from R&D to distribution
3. Technology Services: Ongoing technical support and consulting services for pharmaceutical digitalization

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

ESSENCE provides customized software, system integration, and technology services to pharmaceutical enterprises and government regulators. Its offerings span the entire pharmaceutical value chain — drug R&D, production, warehousing, circulation, and sales — through two main business lines: Intelligent Medicine (digital supervision platforms for drug, food, and medical device safety) and Intelligent Manufacturing (TcmMES, pharmaceutical process knowledge management, and AI-driven pharmacist on-duty management).

Product overview

ZedaEssence (泽达易盛) is a pharmaceutical digitalization solutions provider operating two main business segments: Intelligent Manufacturing and Intelligent Supervision. The platform integrates cloud computing, big data, and AI technologies to serve the entire pharmaceutical industry chain. Key products include TcmMES (manufacturing execution system), Pharmaceutical Process Knowledge Management System, Drug Circulation Control System, and AI-based Pharmacist Management System. Solutions cover drug R&D, production, storage, distribution, and sales with over 180 solutions deployed across 22 provinces, serving 100+ pharmaceutical enterprises, 100+ market regulatory units, and 10,000+ pharmacies.

Differentiator

Problem solved

Functional benefit

Products and services

• TcmMES (Production Manufacturing Execution System) Manufacturing Execution System for pharmaceutical production, enabling digitalized and intelligent production manufacturing management and control for pharmaceutical enterprises.
• Pharmaceutical Process Knowledge Management System Pharmaceutical Process Knowledge Management System for managing and leveraging pharmaceutical manufacturing expertise and documentation across the drug production lifecycle.
• Drug and Medical Device Circulation Control System Circulation control system for tracking and managing distribution and sales of drugs and medical devices across the pharmaceutical supply chain.
• AI-based Pharmacist On-Duty Management System AI-powered pharmacist on-duty management system using facial recognition to verify attendance and on-duty status, deployed across thousands of retail pharmacies supporting compliance for hundreds of thousands of users.
• Drug Safety Supervision Platform Digital drug safety supervision platform for market regulatory authorities to monitor and ensure pharmaceutical product safety across the supply chain.
• Food Safety Supervision Platform Digital food safety supervision platform for monitoring and regulating food products across distribution channels.
• Medical Device Safety Supervision Platform Safety supervision platform for regulatory oversight of medical device distribution and usage.

Quantifiable outcome

• Full pharmaceutical industry chain digitalization from R&D to sales
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature7 records

Partnerships

Three partnerships are on record, tiered core.

• Zhejiang Jinchun Information Technology Co., Ltd. (controlling stake)coreStrategic or Co-development Partner · 1 January 2019Subsidiary acquired in 2019 to expand business into digital planting/farming domain, extending pharmaceutical industry chain coverage.
• Suzhou Zeda Xingbang Medical Technology Co., Ltd.coreStrategic or Co-development Partner · 1 January 2016Subsidiary acquired in 2016 to expand into intelligent pharmaceutical manufacturing. Joint ISO standard development partner.
• Zhejiang UniversitycoreStrategic or Co-development PartnerDeep academic-industry collaboration for pharmaceutical digitalization R&D. Jointly developed the global first ISO international standard in traditional Chinese medicine production process and collaborated on smart manufacturing innovations.

Scale indicators7 records

Recent moves7 records

Expansion highlights3 records

Direct peers

• Winning Health Technology (卫宁健康): Leading Chinese healthcare IT vendor focused on hospital EMR, clinical information systems, and regional health information platforms. Comparable to ESSENCE because both sell verticalized healthcare software to regulated institutional buyers across China, though Winning skews toward providers while ESSENCE focuses on pharma manufacturers and regulators.
• B-Soft (创业慧康): Chinese healthcare IT company providing hospital information systems, regional health platforms, and medical insurance informatics. Comparable to ESSENCE as a publicly listed domestic health-IT vendor selling software solutions to healthcare and government customers in China.
• Wonders Information (万达信息): Chinese IT vendor specializing in government informatization, social security, and healthcare regulatory systems. Highly comparable to ESSENCE because both build digital supervision platforms for Chinese government regulators and serve as long-term government technology partners.
• DHC Software (东华软件): Large Chinese IT services firm with a dedicated healthcare division offering hospital information systems, medical insurance platforms, and pharma-related solutions. Comparable to ESSENCE in selling digitalization solutions to Chinese hospitals, regulators, and pharmaceutical enterprises.

Broad incumbents

• Neusoft (东软集团): Diversified Chinese IT conglomerate with significant healthcare IT operations including hospital information systems, regional health platforms, and medical device software. Broader portfolio than ESSENCE but overlaps heavily in Chinese healthcare software.
• Yonyou Network (用友网络): China's largest enterprise software vendor offering ERP, cloud, and industry-specific solutions including pharmaceutical manufacturing and quality management. Comparable to ESSENCE in providing digitalization software for Chinese pharma manufacturers, but at much larger scale and broader scope.
• Kingdee International (金蝶国际): Major Chinese enterprise cloud and ERP vendor with growing life sciences and pharmaceutical manufacturing offerings. Comparable to ESSENCE as a competitor for enterprise digitalization contracts with Chinese pharmaceutical companies, particularly for ERP and production management.
• Alibaba Health Information Technology (阿里健康): Hong Kong-listed Alibaba Group healthcare affiliate operating pharma e-commerce, traceability, and digital health platforms in China. Comparable to ESSENCE as a major Chinese digital health/pharma platform, though Alibaba Health is far larger and focused on consumer/retail channels rather than manufacturing supervision.
• JD Health (京东健康): JD.com's healthcare arm providing online pharmacy, healthcare services, and supply chain technology. Comparable to ESSENCE in operating digital pharma infrastructure in China, though JD Health is consumer/retail-oriented rather than focused on manufacturing execution and regulatory supervision.

Emerging players

• Veeva Systems: Global cloud software provider specializing in pharmaceutical and life sciences, offering quality, regulatory, clinical, and commercial solutions. Comparable to ESSENCE because both build verticalized pharma software (regulatory, manufacturing, quality), though Veeva targets multinational pharma while ESSENCE focuses on Chinese TCM and regulatory customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds6 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ESSENCE